{"id":1017040,"date":"2026-11-05T03:04:33","date_gmt":"2026-11-05T08:04:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"},"modified":"2026-11-05T03:04:33","modified_gmt":"2026-11-05T08:04:33","slug":"pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","title":{"rendered":"Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026"},"content":{"rendered":"

\nCompany to hold a conference call at 8:30 a.m. ET
\n<\/h2>\n
\n

DURHAM, N.C., Nov. 04, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (\u201cPelthos\u201d), today announced it will report third quarter 2026 financial results on Thursday, November 12, 2026. The company will hold a conference call followed by a question-and-answer period at 8:30 a.m. Eastern Time.<\/p>\n

Details for the conference call can be found below:<\/p>\n\n\n\n\n\n\n
Date:<\/td>\nThursday, November 12, 2026<\/td>\n<\/tr>\n
Time:<\/td>\n8:30 a.m. Eastern Time<\/td>\n<\/tr>\n
Toll Free:<\/td>\n1-877-451-6152<\/td>\n<\/tr>\n
International:<\/td>\n1-201-389-0879<\/td>\n<\/tr>\n
Conf.ID:<\/td>\n13763737<\/td>\n<\/tr>\n<\/table>\n

\n
Call.Me: Participants can use the dial-in numbers above or click the CallMe link<\/a> for instant telephone access to the event. The CallMe link will be activated 15 minutes prior to the scheduled call start time.<\/p>\n

Webcast: Participants can also join via the web at
https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1782128&tp_key=f03f47add7<\/a><\/p>\n

\n About Pelthos Therapeutics<\/strong>
\n
Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products that address unmet patient needs. ZELSUVMI\u00ae (berdazimer) topical gel, 10.3%, the company\u2019s lead product, is the first and only prescription therapy approved for use at home by patients, parents, and caregivers to treat molluscum contagiosum. The company\u2019s portfolio of assets includes XEPI\u00ae (ozenoxacin) Cream, 1%, a topical treatment for impetigo, and XEGLYZE\u00ae (abametapir), a topical treatment for head lice. More information is available at\u00a0https:\/\/pelthos.com\/<\/a>. Follow Pelthos on\u00a0LinkedIn<\/a>\u00a0and\u00a0X<\/a>.<\/p>\n

\n Contacts<\/strong>\n <\/p>\n

\n Investors:<\/strong>
\n
LifeSci Advisors, LLC
Mike Moyer, Managing Director
mmoyer@lifesciadvisors.com<\/a><\/p>\n

\n Media:<\/strong>
\n
Jude Gorman \/ Dylan O\u2019Keefe
Collected Strategies
Pelthos-CS@collectedstrategies.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Company to hold a conference call at 8:30 a.m. ET DURHAM, N.C., Nov. 04, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (\u201cPelthos\u201d), today announced it will report third quarter 2026 financial results on Thursday, November 12, 2026. The company will hold a conference call followed by a question-and-answer period at 8:30 a.m. Eastern Time. Details for the conference call can be found below: Date: Thursday, November 12, 2026 Time: 8:30 a.m. Eastern Time Toll Free: 1-877-451-6152 International: 1-201-389-0879 Conf.ID: 13763737 Call.Me: Participants can use the dial-in numbers above or click the CallMe link for instant telephone access to the event. The CallMe link will … <\/p>\n

Continue reading “Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1017040","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company to hold a conference call at 8:30 a.m. ET DURHAM, N.C., Nov. 04, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (\u201cPelthos\u201d), today announced it will report third quarter 2026 financial results on Thursday, November 12, 2026. The company will hold a conference call followed by a question-and-answer period at 8:30 a.m. Eastern Time. Details for the conference call can be found below: Date: Thursday, November 12, 2026 Time: 8:30 a.m. Eastern Time Toll Free: 1-877-451-6152 International: 1-201-389-0879 Conf.ID: 13763737 Call.Me: Participants can use the dial-in numbers above or click the CallMe link for instant telephone access to the event. The CallMe link will … Continue reading "Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-05T08:04:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDQwMiM3OTQ2MDIxIzUwMDEyNjcxOQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026\",\"datePublished\":\"2026-11-05T08:04:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\"},\"wordCount\":278,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MDQwMiM3OTQ2MDIxIzUwMDEyNjcxOQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\",\"name\":\"Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MDQwMiM3OTQ2MDIxIzUwMDEyNjcxOQ==\",\"datePublished\":\"2026-11-05T08:04:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MDQwMiM3OTQ2MDIxIzUwMDEyNjcxOQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MDQwMiM3OTQ2MDIxIzUwMDEyNjcxOQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","og_locale":"en_US","og_type":"article","og_title":"Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk","og_description":"Company to hold a conference call at 8:30 a.m. ET DURHAM, N.C., Nov. 04, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (\u201cPelthos\u201d), today announced it will report third quarter 2026 financial results on Thursday, November 12, 2026. The company will hold a conference call followed by a question-and-answer period at 8:30 a.m. Eastern Time. Details for the conference call can be found below: Date: Thursday, November 12, 2026 Time: 8:30 a.m. Eastern Time Toll Free: 1-877-451-6152 International: 1-201-389-0879 Conf.ID: 13763737 Call.Me: Participants can use the dial-in numbers above or click the CallMe link for instant telephone access to the event. The CallMe link will … Continue reading \"Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-05T08:04:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDQwMiM3OTQ2MDIxIzUwMDEyNjcxOQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026","datePublished":"2026-11-05T08:04:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"},"wordCount":278,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDQwMiM3OTQ2MDIxIzUwMDEyNjcxOQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","name":"Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDQwMiM3OTQ2MDIxIzUwMDEyNjcxOQ==","datePublished":"2026-11-05T08:04:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDQwMiM3OTQ2MDIxIzUwMDEyNjcxOQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MDQwMiM3OTQ2MDIxIzUwMDEyNjcxOQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pelthos-therapeutics-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1017040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1017040"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1017040\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1017040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1017040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1017040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}